Clinical complete response after nivolumab administered as a third-line treatment for unresectable advanced gastric cancer with peritoneal dissemination: A case report.
Clinical complete response after nivolumab administered as a third line treatment for unresectable advanced gastric cancer with peritoneal dissection: A case report